Combination therapy with cyclosporine and interleukin-4 or interleukin-10 prolongs survival of synergeneic pancreatic islet grafts in nonobese diabetic mice: islet graft survival does not correlate with mRNA levels of type 1 or type 2 cytokines, or (Q73987277)
Jump to navigation
Jump to search
scientific article published on 01 December 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combination therapy with cyclosporine and interleukin-4 or interleukin-10 prolongs survival of synergeneic pancreatic islet grafts in nonobese diabetic mice: islet graft survival does not correlate with mRNA levels of type 1 or type 2 cytokines, or |
scientific article published on 01 December 1997 |
Statements
Combination therapy with cyclosporine and interleukin-4 or interleukin-10 prolongs survival of synergeneic pancreatic islet grafts in nonobese diabetic mice: islet graft survival does not correlate with mRNA levels of type 1 or type 2 cytokines, or transforming growth factor-beta in the islet grafts (English)
A Rabinovitch
W L Suarez-Pinzon
O Sorensen
R V Rajotte
1 December 1997